These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 3465171

  • 1. Patterns of growth from birth to maturity in infants and children with congenital adrenal hyperplasia.
    Clayton GW.
    Acta Endocrinol Suppl (Copenh); 1986; 279():295-304. PubMed ID: 3465171
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Growth pattern during the first 36 months of life in congenital adrenal hyperplasia (21-hydroxylase deficiency).
    Gasparini N, Di Maio S, Salerno M, Argenziano A, Franzese A, Tenore A.
    Horm Res; 1997; 47(1):17-22. PubMed ID: 9010713
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 7. Growth in congenital adrenal hyperplasia.
    Bergstrand CG.
    Acta Paediatr Scand; 1966 Sep; 55(5):463-72. PubMed ID: 5970748
    [No Abstract] [Full Text] [Related]

  • 8. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
    J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
    [Abstract] [Full Text] [Related]

  • 9. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
    Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A.
    Eur J Endocrinol; 1997 Feb 01; 136(2):188-95. PubMed ID: 9116914
    [Abstract] [Full Text] [Related]

  • 10. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar 01; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 11. [Adult height, pattern of growth and pubertal development in patients with congenital adrenal hyperplasia, salt losing form].
    Gussinyé M, Potau N, Vicens-Calvet E, Albisu MA, Yeste D, Ibáñez L, Audí L, Carrascosa A.
    Med Clin (Barc); 1997 Jan 25; 108(3):87-90. PubMed ID: 9064437
    [Abstract] [Full Text] [Related]

  • 12. Congenital adrenal hyperplasia: lessons from a multinational study.
    Frisch H, Waldhauser F, Lebl J, Solyom J, Hargitai G, Kovacs J, Pribilincova Z, Krzisnik C, Battelino T, MEWPE-CAH Study Group.
    Horm Res; 2002 Jan 25; 57 Suppl 2():95-101. PubMed ID: 12065936
    [Abstract] [Full Text] [Related]

  • 13. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W, Schmidt H, Schwarz HP.
    Horm Res Paediatr; 2011 Jan 25; 75(1):32-7. PubMed ID: 20714115
    [Abstract] [Full Text] [Related]

  • 14. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2009 Oct 25; 94(10):3882-8. PubMed ID: 19622620
    [Abstract] [Full Text] [Related]

  • 15. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May 25; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
    Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
    Arch Dis Child; 2002 Aug 25; 87(2):139-44. PubMed ID: 12138066
    [Abstract] [Full Text] [Related]

  • 17. Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.
    Jääskeläinen J, Voutilainen R.
    Pediatr Res; 1997 Jan 25; 41(1):30-3. PubMed ID: 8979286
    [Abstract] [Full Text] [Related]

  • 18. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
    Bonfig W, Schwarz HP.
    Horm Res Paediatr; 2011 Jan 25; 75(4):264-8. PubMed ID: 21196707
    [Abstract] [Full Text] [Related]

  • 19. [Puberty and growth development in patients with a 21-hydroxylase defect].
    Börger D, Willig RP.
    Monatsschr Kinderheilkd; 1985 Nov 25; 133(11):828-33. PubMed ID: 2934617
    [Abstract] [Full Text] [Related]

  • 20. Auxological and biochemical parameters in assessing treatment of infants and toddlers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Einaudi S, Lala R, Corrias A, Matarazzo P, Pagliardini S, de Sanctis C.
    J Pediatr Endocrinol; 1993 Nov 25; 6(2):173-8. PubMed ID: 8348221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.